TY - JOUR
T1 - Healthcare resource utilization in patients with newly diagnosed atrial fibrillation in the United States
AU - Zeitler, Emily P.
AU - Ronk, Christopher J.
AU - Cockerham, Alex
AU - Huse, Samuel
AU - McKindley, David S.
AU - Kim, Michael H.
N1 - Funding Information:
This work was supported by Sanofi. Support included analytic and writing support. Medical writing and editorial support was provided by Brooke Middlebrook, and Meenakshi Subramanian, Evidence Medical Affairs (Philadelphia, PA, USA) and was funded by Sanofi US Inc.
Funding Information:
Medical writing and editorial support was provided by Brooke Middlebrook, and Meenakshi Subramanian, Evidence Medical Affairs (Philadelphia, PA, USA) and was funded by Sanofi US Inc.
Publisher Copyright:
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2022
Y1 - 2022
N2 - Objectives: To summarize healthcare resource utilization (HCRU) in patients with newly diagnosed (incident) paroxysmal or persistent atrial fibrillation (AF). Methods: This retrospective, observational cohort study assessed HCRU among patients with incident paroxysmal or persistent AF using data from 1 January 2015 to 30 September 2019 in the IBM MarketScan® Research Databases. Results: A total of 50,796 patients were identified in the overall incident AF cohort. Rates of all-cause inpatient hospital stays, all-cause emergency room visits, and all-cause outpatient visits in the overall incident cohort were 46.8, 114.7, and 2,752.7 events per 100 patient-years (PY), respectively. Rates of cardiovascular-related inpatient stays for the overall population were 11.3 events per 100 PY. During follow-up, 50.4% of the overall cohort filled prescriptions for direct-acting oral anticoagulants and 5.0% had catheter ablation. Conclusions: Advances in anticoagulation and ablation have been realized since previously published HCRU analyses of patients with atrial fibrillation. This update suggests that HCRU among patients with incident AF in the US remains high with some subgroups of patients receiving more specialized care.
AB - Objectives: To summarize healthcare resource utilization (HCRU) in patients with newly diagnosed (incident) paroxysmal or persistent atrial fibrillation (AF). Methods: This retrospective, observational cohort study assessed HCRU among patients with incident paroxysmal or persistent AF using data from 1 January 2015 to 30 September 2019 in the IBM MarketScan® Research Databases. Results: A total of 50,796 patients were identified in the overall incident AF cohort. Rates of all-cause inpatient hospital stays, all-cause emergency room visits, and all-cause outpatient visits in the overall incident cohort were 46.8, 114.7, and 2,752.7 events per 100 patient-years (PY), respectively. Rates of cardiovascular-related inpatient stays for the overall population were 11.3 events per 100 PY. During follow-up, 50.4% of the overall cohort filled prescriptions for direct-acting oral anticoagulants and 5.0% had catheter ablation. Conclusions: Advances in anticoagulation and ablation have been realized since previously published HCRU analyses of patients with atrial fibrillation. This update suggests that HCRU among patients with incident AF in the US remains high with some subgroups of patients receiving more specialized care.
UR - http://www.scopus.com/inward/record.url?scp=85126486765&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126486765&partnerID=8YFLogxK
U2 - 10.1080/14737167.2022.2045955
DO - 10.1080/14737167.2022.2045955
M3 - Article
C2 - 35209794
AN - SCOPUS:85126486765
VL - 22
SP - 763
EP - 771
JO - Expert Review of Pharmacoeconomics and Outcomes Research
JF - Expert Review of Pharmacoeconomics and Outcomes Research
SN - 1473-7167
IS - 5
ER -